Table 3.
Characteristics of the study population and mycobiome data.
| Variable | Healthy infants (n = 20) |
Infants with AD (n = 20) |
p-Valuea |
|---|---|---|---|
| Gestational age (weeks) | 39.18 ± 1.22 | 39.53 ± 1.06 | 0.339 |
| Male, n (%) | 10/20 (50.0) | 12/20 (60.0) | 0.525 |
| Birth weight, mean ± SD (g) | 3088.33 ± 264.63 | 3043.58 ± 849.39 | 0.832 |
| SCORAD index | NA | 14.37 ± 18.91 | NA |
| Parental history of allergic diseases [yes, n (%)] | 12/20 (60.0) | 12/19 (63.2) | 0.839 |
| Cord blood eosinophils (%) | 2.53 ± 1.60 | 4.20 ± 1.32 | 0.011 |
| Log-transformed cord blood total serum IgE level, mean ± SD (kUA/L) | −2.02 ± 0.34 | −1.24 ± 0.89 | 0.012 |
| Log-transformed total serum IgE level at 1 year of age, mean ± SD (Kua/L) | 1.11 ± 0.51 | 1.43 ± 0.56 | 0.077 |
AD, atopic dermatitis; n, number; NA, not applicable; SCORAD, SCORing Atopic Dermatitis; SD, standard deviation.
The cord blood eosinophil (%) and log-transformed cord blood total serum IgE levels were significantly increased in infants with AD compared with healthy infants are denoted in bold.
a
Mann–Whitney U-test.